Navigation Links
Varian Medical Systems to Offer CIVCO Medical Solutions' Body Pro-Lok™ for SBRT
Date:7/29/2011

KALONA, Iowa, July 29, 2011 /PRNewswire/ -- CIVCO is pleased to announce the signing of a reseller agreement that would allow Varian Medical Systems to offer CIVCO's Body Pro-Lok to its customers. Introduced in 2008 and installed at over 150 community and academic facilities worldwide, Body Pro-Lok excels as a modular base for indexable patient positioning, secure immobilization and efficient patient transport.

(Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO)

Body Pro-Lok was designed to maximize patient comfort during immobilization for treatment.  Niko Papanikolaou, Ph.D, Chief of the Division Medical Physics at UT San Antonio's Cancer Therapy & Research Center, has worked extensively with the Body Pro-Lok immobilization product. "The Body Pro-Lok system is very effective for SBRT respiration immobilization," said Papanikolaou. "It is highly indexed, provides setup reproducibility and it is an easy and efficient device to use for robust immobilization."

When used with CIVCO's Protura Robotic Patient Positioning System and Universal Couchtop, Body Pro-Lok is part of a complete motion management solution. Protura and Universal Couchtop have been validated with Varian's Clinac® and Trilogy® platforms.  Body Pro-Lok is available worldwide through CIVCO's account representatives, and now also through Varian's sales channels.

About CIVCOCIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO's Radiation Oncology division designs and manufactures products for radiation oncology treatment, including basic patient positioning equipment as well as high technology robotic motion management and advanced patient positioning for SBRT. CIVCO offers patients and clinicians the newest and best technology available to improve patient care.

Corporate information is available at www.CIVCO.com. Media Contact:AAPM In-Booth Contact:Liz Etchells

Jennifer TobinMarketing Communications Specialist

Trade Show CoordinatorPhone: 319-248-6551

Mobile: 631-903-4084Mobile: 319-541-9672

AAPM Booth #817Email: liz.etchells@civco.comCOPYRIGHT © 2011. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. BODY PRO-LOK AND LASER-LOK ARE TRADEMARKS OF CIVCO. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2011C-0687


'/>"/>

SOURCE CIVCO Medical Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
(Date:2/23/2017)... , February 23, 2017 Obese ... increasing caseload for varicose veins in their body. The ... are prompting the adoption of endovenous laser therapy for ... endovenous laser therapy market, published by Future ... lifestyle choices and consequences of obesity have collectively factored ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 2017 , ... The California State University Institute for Palliative Care ... interested in palliative care education and research. The Symposium, “Innovate. Investigate. Educate: Advancing ... Diego on Sept. 28 and 29, 2017, on the campus of California State University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association ... marketing programs at the annual Building Better Radiology Marketing Programs conference, held ... in Fort Worth, Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, ... be participating in Rare Disease Day events, hosted by the Rare Disease Legislative ... Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews with ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
Breaking Medicine News(10 mins):